The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ALLERGAN PLC SHS G0177J108 13,336 63,500 SH Call SOLE   63,500 0 0
ALLERGAN PLC SHS G0177J108 27,530 131,089 SH   SOLE   131,089 0 0
ALPHABET INC CAP STK CL C 02079K107 19,681 25,500 SH   SOLE   25,500 0 0
ASHLAND GLOBAL HLDGS INC COM 044186104 49,335 451,417 SH   SOLE   451,417 0 0
ATHENE HLDG LTD CL A G0684D107 24,787 516,508 SH   SOLE   516,508 0 0
CADENCE DESIGN SYSTEM INC COM 127387108 221,006 8,763,135 SH   SOLE   8,763,135 0 0
GCP APPLIED TECHNOLOGIES INC COM 36164Y101 67,707 2,531,097 SH   SOLE   2,531,097 0 0
MCKESSON CORP COM 58155Q103 14,045 100,000 SH Call SOLE   100,000 0 0
PACIRA PHARMACEUTICALS INC COM 695127100 25,045 775,388 SH   SOLE   775,388 0 0
PTC INC COM 69370C100 30,076 650,000 SH   SOLE   650,000 0 0
SHERWIN WILLIAMS CO COM 824348106 22,037 82,000 SH   SOLE   82,000 0 0
UNITED TECHNOLOGIES CORP COM 913017109 21,924 200,000 SH   SOLE   200,000 0 0
VALEANT PHARMACEUTICALS INTL COM 91911K102 10,361 713,550 SH   SOLE   713,550 0 0